| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Morris Gabriel S | CFO, Director | C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES | /s/ Gabriel Morris | 20 Jun 2025 | 0001889967 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMMX | Common Stock | Purchase | $5,071 | +2,225 | +0.78% | $2.28 | 288,059 | 18 Jun 2025 | Direct | F1 |
| holding | IMMX | Common Stock | 270,844 | 18 Jun 2025 | See footnote | F2 | |||||
| holding | IMMX | Common Stock | 24,141 | 18 Jun 2025 | See footnote | F3 |
| Id | Content |
|---|---|
| F1 | Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein. |
| F3 | Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein. |